Candidates may have requested information on its governance and decisions, including copies of board minutes, outcomes, current liabilities, ongoing discussions with other parties, including the government, yet-to-be-announced decisions, and its processes for managing issues such as conflicts of interest. …
Logical to gather more information because of the legal liability for decisions
September 23, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Immutep posts encouraging Phase 2 results as 'Efti' spurs robust anti-tumour activity
November 13, 2025 - - Australian Biotech -
PYC Therapeutics appoints Peter Coleman as new Chair as part of board renewal
November 13, 2025 - - Australian Biotech -
New gene discoveries improve diagnosis of inherited heart disease
November 13, 2025 - - Australian Biotech -
Chimeric Therapeutics reports strong early results from CHM CDH17 Phase 1/2 trial
November 13, 2025 - - Australian Biotech -
Australia joins global WHO task force to tackle antimicrobial resistance
November 13, 2025 - - Latest News -
New post-market review workplan focuses on real-world data and patient outcomes
November 13, 2025 - - Latest News -
Government adds new first-line treatment to the PBS for deadly blood cancer
November 13, 2025 -